GOTEBORG, Sweden, April 22, 2021 /PRNewswire/ — Today, Getinge announces clearance from the US FDA of several new software options for the Servo-u and Servo-n ventilators. In addition to the latest ...

(HealthDay News) — For patients with heart failure with reduced ejection fraction and predominantly central sleep apnea, adaptive servo-ventilation does not improve outcome, according to a study ...

The Maquet SERVO-i ventilator battery module has been recalled due to the battery having a shorter run time than expected, according to the American Society of Anesthesiologists. The FDA assigned a ...

WAYNE, New Jersey, July 7, 2020 /PRNewswire/ -- US Food & Drug Administration (FDA) clears Servo-air® mechanical ventilator for use with adult and pediatric patients dependent on intensive care ...

To the Editor: Cowie et al. (Sept. 17 issue) 1 report on the results of the Treatment of Sleep-Disordered Breathing with Predominant Central Sleep Apnea by Adaptive Servo Ventilation in Patients with ...

Please provide your email address to receive an email when new articles are posted on . Treatment with adaptive servo-ventilation for 12 months improved disease-specific quality of life scores. At 12 ...

The Maquet Getinge Group is recalling 90,000 defective batteries used with the SERVO-i ventilator system, the US Food and Drug Administration (FDA) announced May 7. The FDA said some battery modules ...

MONTREAL — The treatment of central sleep apnea in heart failure patients was in the spotlight here at CHEST 2015, as experts debated whether or not to completely reject the use of adaptive servo ...

Please provide your email address to receive an email when new articles are posted on . ORLANDO, Fla. — In a substudy of CAT-HF, patients with HF, sleep-disordered breathing and an implantable cardiac ...